CHAPTER 31

MANIFESTIONS OF PRIMARY
IMMUNO-DEFFICIENCY DISEASES

Contents << Previous Chapter Next Chapter >> Search

 
Different clinical manifestations occur due to deficiency in immunoglobulins. These may be non-specific or specific manifestations related to the specific type of the immunoglobulin.

Non-specific cutaneous manifestations

These are caused by different factors mainly the following:-

Infections and ulceration:

Recurrent furuncles or abscesses.

Bullous impetigo with clear blisters.

Cutaneous ulcers due to secondary infection by viral diseases such as herpes simplex virus or varicella-zoster viruses due to T-lymphocyte defects .

Viral warts.

Vesicobullous lesions:

A vesicular presentation of the hyper-IgE syndrome in infancy has been described .

Candidiasis . Refractory cutaneous and mucosal candida infections may present with signs of severe immunodeficiency disorders, particularly severe combined immunodeficiency due to T-lymphocyte defects.

Morbilliform eruptions. These are early feature of severe combined immunodeficiency disease and of DiGeorge‘s syndrome .

Petechiae. Petechiae, due to thrombocytopenia, are a highly characteristic feature of the Wiskott-Aldrich syndrome, and may also occur in Fanconi‘s anemia , dyskeratosis congenita and the Chediak-Higashi syndrome.

Erythroderma. A combination of erythroderma of early onset with failure to thrive is highly suggestive of immunodeficiency .It is a rather non-specific feature of immunodeficiency in infancy.

Eczema. Eczema is a characteristic feature of certain well-established immunodeficiency disorders such as the Wiskott-Aldrich syndrome, Agammaglobulinemia, selective IgA deficiency , selective IgM deficiency, and ataxia telangiectasia .

Lupus erythematosus. There is an increased incidence of systemic lupus erythematosus in patients with IgA deficiency, and skin lesions closely resembling discoid lupus erythematosus .

   

SYNDROMES ASSOCIATED
WITH IMMUNODEFFICIENCY DISEASES

  1. Bruton‘s Agammaglobulinemia

    This is a rare immunodeficiency, confined to boys, inherited as an X-linked recessive trait. During the first 6 months, the infant is usually protected by the maternal antibodies.

    Clinical Features

    Eczema clinically indistinguishable from atopic eczema may appear in boys with low levels of the circulating IgE .

    Affected boys become liable to have serious pyogenic infection, predominantly affecting the middle ear, sinuses and lungs .

    Pyogenic cutaneous infections are also common including furuncles, abscesses and cellulitis. These types of infections are most often caused by Staphylococcus aureus and Group A streptococci.

    Chronic lung disease.

    Impairment of hearing .

    Growth failure.

  1. Selective IgA deficiency.

    Clinical Manifestation

    Fatal varicella .

    Chronic Candida granuloma .

    Atopic eczema and asthma .

    Recurrent bacterial infections of the respiratory tract .

    Autoimmune disorders may complicate IgA deficiency mainly SLE, rheumatoid arthritis, dermatomyositis, pernicious anemia, vitiligo and idiopathic thrombocytopenic purpura.

    Anaphylactic reactions following transfusion of blood or administration of immunoglobulin, due to the presence of IgE and anti-IgA antibodies.

  1. Selective IgM deficiency

    Clinical Manifestations

    Eczema.

    Large Viral Warts.

    Meningococcal and pneumococcal infections.

  1. Hyper-IgM syndrome.

    Hyper-IgM syndrome is an autosomal X- linked affects predominantly boys .

    General Features

    Recurrent bacterial infections, particularly tonsillitis, otitis media and pneumonia, usually starting during the first or second year of life.

    Skin manifestations : extensive viral warts .

    Mucous membranes manifestations : stomatitis, gingivitis and oral ulceration occurring secondary to neutropenia.

    Blood picture : IgM is elevated while IgG , IgA and IgE are reduced.

    Neutropenia .

  1. T-lymphocyte immunodeficiency (DiGeorge syndrome, Thymic dysplasia)

    This syndrome reflects an abnormal development of the third and fourth branchial (pharyngeal) pouches.

    Clinical Manifestations

    Skin manifestations: affected children have skin lesions simulating “seborrhoeic dermatitis“, atopic dermatitis, and ‘maculopapular rashes‘ .

    Persistent oral candidiasis is a common presenting feature, in those infants who survive the neonatal period.

    General manifestations

    Absence of the parathyroid glands .

    Defects of the heart and great vessels.

    Defects of the head and neck, and thymus hypoplasia leading to a congenital T-cell defect.

  1. Severe combined immunodeficiency

    This term is applied to a syndrome comprising several genetically distinct disorders with similar clinical and immunological features.

    This syndrome is characterized by metabolic defects with deficiency in adenosine deaminase, purine nucleoside phosphorylase enzymes, deficiency of DNA-binding protein and a defect in the production of interleukin-2. Death is common in the first few months of life .

    Clinical features

    These patients have marked deficiencies both of T- and B-lymphocyte function.

    Mucocutaneous manifestations

    Mucocutaneous and systemic candidiasis is the most common manifestations. Dermatophyte infections may occur and may present as a chronic and refractory napkin dermatitis.

    ‘Ichthyosiform erythroderma‘ with ‘alopecia and absence of eyelashes and eyebrows‘ or ‘ectodermal dysplasia‘.

    Toxic epidermal necrolysis like lesions .

    Viral infections manifesting with skin ulcerations particularly in the perineal area, the oral mucosa or the tongue . Severe varicella-zoster infections may also occur.

    General manifestations

    Recurrent infections mainly pneumonia , viral infections due to Cytomegalovirus , measles or pneumocystis Carini .

    Chronic diarrhea (due most commonly to rotavirus, Campylobacter, or to parasites such as Giardia or Cryptosporidia .

Treatment

A bone-marrow graft is the only effective treatment.

  1. Bare lymphocyte syndrome

    This syndrome is transmitted as an autosomal recessive trait, characterized by defect in expression of histocompatibility antigens on B- and T-lymphocytes and on monocytes, either of class I or class II .

    Class I antigens are particularly important for viral cytotoxicity and both class I and class II antigens are required for antigen presentation to T-lymphocytes. Death in early childhood is common .

    Clinical Manifestation

    Increased susceptibility to candida infections.

    Lung infections caused by different organisms mainly pneumocystis carini. Severe diarrhea .

    Septicaemia and marked vulnerability to viral infections, including herpes virus hominis, Coxsackievirus and poliomyelitis.

  1. Omenn‘s syndrome

    This is an autosomal recessive inherited familial syndrome , where most of the manifestations are cutaneous . It appears that the disorder reflects proliferation of T-lymphocytes at the expense of the B-lymphocyte.

    The disease has a rapidly fatal course, with failure to thrive and recurrent infection .

    Skin manifestations

    Erythematous scaly rash and confluent erythroderma .

    General manifestations

    Hepatospleenomegaly and generalized lymphadenopathy .

    Chronic diarrhea.

    Lymphoma may develop in some cases.

    Eosinophilia and lymphocytosis.

    Loss of B-cells and falling levels of all immunoglobulin other than IgE, which may be elevated.

Treatment

Bone marrow transplantat offers the only real therapeutic hope for these infants .

  1. Wiskott-Aldrich syndrome

    This is a genetically determined disorder characterized by:

    Thrombocytopenic purpura.

    Eczema and recurrent infections.

    Death in childhood is common. The gene for the Wiskott-Aldrich syndrome has been mapped to Xp11.

    Lymphocytes, neutrophils and platelets from patients with Wiskott-Aldrich syndrome have been shown to have altered expression of a heavily glycosylated surface protein called sialophorin (CD43 ) .

Blood Picture

Thrombocytopenia. Platelets are small and fail to aggregate with reduced platelet production and number .

Immunoglobulins:

Hypercatabolism of immunoglobulins.

Raised IgE and decreased IgG .

Absent isohaemoagglutinins .

IgG2 subclass, is frequently impaired .

Antibody responses to protein antigens are less severely impaired.

Lymphocytes are small and show characteristic morphological abnormalities.

Treatment

Fresh platelets transfusion for acute bleeding.

Spleenectomy reduces the danger of bleeding, increases the platelet count and improves platelet function. Spleenectomy increases the risk of fatal septicaemia, but this risk can be minimized by long-term prophylactic administration of antibiotics, particularly Cotrimoxazole .

Gammaglobulin: intravenous immunoglobulin administration has a definite place in the control of infection, where antibiotic therapy alone is inadequate.

Gamma globulins by the intramuscular route are contra-indicated because of the risk of hemorrhage at the injection site .

Bone marrow transplantation.

Genetic counseling of parents and possible female carriers in the family is important.

  1. Ataxia telangiectasia

    Ataxia telangiectasia is an autosomal recessive disorder characterized by:

    Skin manifestations

    An extensive scaly erythematous rash may be an early feature in infants who do not die immediately, progressing to erythroderma, and associated with alopecia .

    Atrophy with mottled hypo- and hyperpigmentation, café au lait macules, often in a dermatomal distribution, photosensitivity, premature graying of the hair, acanthosis nigricans and eczema are common manifestations.

    General Manifestations

    Mucous membrane manifestations.

    Mucocutaneous telangiectasia .

    Progressive ataxia .

    Recurrent sinus and lung infections.

    Combined immunodeficiency .

    Increased liability to malignancy .

    Recurrent episodes of acute metabolic illness.

    Striking neurological problems including fits.

    Lactic acidosis occurs within the first few days of life.

    Death may occur rapidly unless the diagnosis is made and treatment is started early.

    Bacterial and viral infections cause high mortality.

Diagnosis

Diagnosis is confirmed by identification of a characteristic pattern of organic aciduria.

Prenatal diagnosis can be carried out in a number of ways and affected fetuses can be treated by maternal biotin.

Blood picture

The peripheral blood count generally reveals eosinophilia and lymphopenia. IgA deficiency and T-cell defects are very common.

Treatment

Treatment is with biotin 10-40 mg daily.

  1. Biotinidase deficiency

    Biotin-dependent carboxylases appear to be important for normal immune function.

Clinical Manifestations

A scaly erythematous rash appears in the interdigital webs , in the flexures of the groins and axilla.

Periorificial eczematous eruption that is often confused with the rash of zinc deficiency.

Alopecia is of the diffuse type and there may be alopecia totalis.

Candida is often isolated from the rash.

Immunodeficiency has been reported, particularly absent delayed hypersensitivity skin tests to Candida, and absent in vitro T-lymphocyte responses to Candida antigen.

Diagnosis

The findings of low serum and urine biotin levels, and a low serum biotinidase level confirm the diagnosis.

Treatment

Treatment with biotin 5-10 mg daily is very effective, though loss of vision and hearing due to long-standing untreated disease may not recover.

  1. Griscelli‘s syndrome

    This is a rare disorder, probably transmitted as an autosomal recessive trait, in which combined immunodeficiency is associated with partial albinism and an absence of cutaneous langerhans cells .

    Hair of eyebrows and eyelashes are silvery-gray from early childhood.

  1. Neutrophil disorders

    This syndrome may be congenital or acquired .

    Congenital neutropenia. Persistent chronic neutropenia of childhood results in high mortality rate. This is genetically transmitted both as an autosomal recessive and autosomal dominant .

    Acquired neutropenia. This may be due to drugs , bone marrow hypoplasia and transient in the course of febrile illnesses .

General Features

Presentation is usually within the first few months of life. Neutrophils appear to be responsible principally for the protection of those surfaces of the body that are in direct contact with the external environment.

Recurrent skin infections

When the neutrophil count is less than 500/mm3, patients are at considerable risk of infection.

Cutaneous abscesses, furunculosis and cellulitis are the most frequent types of infection. Otitis media , stomatitis and gingivitis are common. These are usually caused by staphylococcus aureus and less common by Gram-negative organisms such as Escherichia coli and pseudomonas species.

Systemic infections

Other common infections include lung abscesses , pneumonia, meningitis and septicaemia are dangerous complications.

Fungal infections are a particular problem, especially infections caused by Aspergillus and Candida species.

Periorificial eczematous eruption : This is often confused with the rash of zinc deficiency.

Treatment

Bone marrow transplant.

Cyclical Neutropenia

This is an autosomal dominant disorder in which the circulating neutrophils disappear at regular intervals of about 21 days.

Clinical Manifestations

The manifestations first appear in childhood presenting with :

Recurrent pyrexia

Oral ulceration

Cervical lymphadenopathy .

Cutaneous furunculosis.

Treatment

The condition tends to improve spontaneously after a few years. Treatment with human granulocytes and colony-stimulating factor appears promising.

Neutropenia and associated syndromes

Neutropenia also occurs as a part of certain syndromes :

Pancytopenia as in Fanconi‘s anemia.

Dyskeratosis congenita.

Chediak-Higashi syndrome.

Griscelli‘s syndrome.

Secondary event in the primary immunoglobulin deficiencies .

  1. Fanconi‘s anemia

    The syndrome is transmitted as an autosomal recessive trait. Children with Fanconi‘s anemia are generally small, and have a history of low birth weight. Death is usually within a few years of the first signs of bone marrow failure.

Clinical Manifestations

Skin manifestations

Easy bruising is generally the early presenting symptom, and most often appear between the ages of 4-10 years.

Cutaneous hyperpigmentation and skeletal anomalies are characteristic. Macular brownish pigmentation, either resembling freckles and occurring mainly on the sun-exposed areas. The abdomen, genital area and flexures appear to be predominantly affected .

Guttate macular hypopigmentation is often present in affected areas.

General manifestations

Progressive bone marrow failure during childhood and adolescence.

Thrombocytopenia, anemia and leucopenia are usual, and the bone marrow is aplastic.

The principal skeletal abnormality is the absence or hypoplasia of at least one of the thumbs.

Hypoplasia or absence of the radius is also common.

Structural renal abnormalities are also frequently present.

Intelligence is usually unimpaired.

There is a high incidence of leukemia and other malignancies in these children.

There is a high incidence of diabetes and of neoplastic disease .

Treatment

Bone marrow function can be stimulated with corticosteroids and with the androgenic steroid, oxymethalone. Bone marrow transplant has been used successfully to treat patients, but care must be taken to avoid the use of alkylating agents in pretransplanted cases.

  1. Dyskeratosis congenita

    This is an X-linked form of progressive marrow failure, which has in the past been greatly confused with Fanconi‘s anemia. The non-hematological features are however entirely distinctive.

  1. Hyper IgE -syndrome

    The hyper-IgE syndrome is a primary immuno-deficiency state transmitted by an autosomal dominant gene. This is characterized by recurrent staphylococcal infections and markedly raised serum IgE levels.

Clinical Manifestations

Skin manifestations

Affected children have skin rash that may appear as early as the first few days of life, which may be vesicular.

An eczematous rash appears, which is excoriated, papular and pustular, more frequent on the scalp. The scalp margins and the proximal flexures such as the axillae, groins and neck are also common sites .

Bacterial skin infections such as furunculosis. Skin abscesses tend to favor the scalp, face and neck.

General manifestations

Candida Infections of the ears, sinuses, joints and viscera are also common. Oral candidiasis and candida nail infections.

Pneumatocoeles may lead to aspergillomata.

Recurrent lung infections by staphylococcus aureus. Infection is also seen with haemophilus influenza, pneumococci, group A streptococci that may lead to the development of pneumatocoeles , lung abscesses and empyemas.

Growth failure may be prominent in affected children, and some patients have had unexplained osteoporosis, predisposing to frequent fractures .

Pathology

Peripheral blood eosinophilia may be marked, up to 50-60% .

Serum IgE levels are consistently very high even in infancy.

Elevated IgD levels.

IgG, IgA and IgM levels are usually unremarkable.

Great increase in circulating total IgE.

Patients show strongly positive immediate wheal and flare responses on skin prick testing with foods and commonly inhaled allergens, as well as bacteria and fungal antigens .

Peripheral blood lymphocytes are generally normal, and no abnormality of T-cells.

Treatment

Antibiotic prophylaxis.

Cimetidine is often given to those who respond poorly to antibiotics alone.

Candida infections should be treated topically with oral ketocazole or the new antifungal preparation such as itraconazole.

Persistent pneumatocoeles should be excised .

  1. Leukocyte Adhesion Deficiency

    This disorder is inherited as an autosomal recessive trait, which is characterized by leukocyte dysfunction. This leads to absence of pus in tissue lesions clinically and histologically.

    Abnormalities of lymphocyte function are also present, particularly diminished natural killer-cell (NK) and T-cell cytotoxic functions.

Clinical Manifestations

Recurrent cellulitis, abscesses and ulceration of the skin and soft tissues are the main manifestations. The organisms usually isolated from these abscesses are either staphylococcus aureus, or Gram-negative bacteria such as Escherichia coli or pseudomonas.

Recurrent otitis media and poor wound healing may be an important presenting feature.

Superficial Candida infections are common.

Ulcerative stomatitis and severe periodontal disease, leading to premature loss of teeth are very frequent problems.

Peritonitis is common and frequently causes serious complications.

Delayed separation of the umbilical cord and omphalitis.

Diagnosis

Definitive laboratory diagnosis depends upon the demonstration of deficient surface expression of CD11a, CD11b and CD11c on polymorphs, lymphocytes and monocytes.

Prenatal diagnosis is available requiring fetal blood sampling.

Treatment

Antibiotics .

Neutrophil infusions.

Bone marrow grafting .

  1. Chronic granulomatous diseases

    Chronic granulomatous disease is an inherited disorder of phagocyte bactericidal function, characterized by the development of granulomatous lesions in many tissues. Short stature is a prominent clinical feature in children and adults with chronic granulomatous disease. Survival rate is variable but improvement occurs in about 50% of patients. The onset of symptoms after infancy predicts a better prognosis.

Pathology

In chronic granulomatous disease, phagocytes are able to ingest bacteria normally, but cannot subsequently kill them. The same abnormality is also present in eosinophils and mononuclear phagocytes. The intracellular survival of the ingested bacteria leads to the development of granulomata in lymph nodes, skin, lungs, liver, gastrointestinal tract or bone.

Clinical Features

Neonatal pustulosis is commonly the first sign of the disease.

Empetiginized periorificial rash around the nostrils, ears, mouth and eyes, perianal abscesses are highly characteristic features.

Nodular lesions and necrotic ulcers.

Subcutaneous nodules may develop at immunization sites, and these also tend in time to ulcerate.

Poor healing of surgical wounds, discharging nodular skin lesions, are highly characteristic and are a regular features.

Enlargement of the superficial and suppuration of lymph nodes.

Other frequent findings include:

Chronic suppurative paronychia.

Folliculitis of the scalp .

Ulcerative stomatitis.

Infections occur in other organs particularly the lungs, the visceral lymph nodes, liver and bones.

Pulmonary disease is prominent, with recurrent pneumonia, empyemas and lung abscess formation .

Gastrointestinal manifestations include: malabsorption, perianal abscesses, fistulae and oral ulceration. The characteristic manifestations are obstructive lesions associated with granulomatous infiltration .

Blood Picture

Peripheral blood leucocytosis is characteristic, reflecting increased numbers of circulating neutrophils.

Microcytic hypochromic anemia .

Levels of the three major classes of immunoglobulin are increased, with increased or normal IgE.

Treatment

Skin hygiene.

Pyrexia should be investigated carefully to reveal the site of infection and the responsible microorganism .

Antibiotics should be chosen carefully and therapy should be vigorous.

Continuous antibiotic treatment, with trimethoprim-sulphamethoxazole (Bactrim, Septrin) or with Trimethoprim alone, is now a standard line of treatment

Continuous antifungal therapy with ketoconazole does not appear to be effective in preventing Aspergillus but it is hoped that itraconazole, currently under evaluation, will prove to be superior.

Subcutaneous interferon-gamma, globulins may have a good response.

Blood transfusions may be required to treat anemia.

Systemic corticosteroids for intestinal obstruction .

Bone marrow transplant.

  1. Schwachman‘s syndrome

    This syndrome may be transmitted as an autosomal recessive trait. It is characterised by:

    Combination of malabsorption and failure to thrive.

    Neutropenia due to pancreatic exocrine insufficiency .

    Metaphyseal chondrodysplasia, which tends to result in deformities, particularly affecting the femoral heads.

Clinical Features

Cutaneous Manifestations

A symmetrical ‘eczematous‘ rash has been reported in some patients and the occasional association of thrombocytopenic purpura and eczema may suggest the Wiskott-Aldrich syndrome. Cutaneous abscesses may be extensive.

General manifestations

Neutropenia is an important component of the disorder, though it may not become apparent during the first few years of life. Thrombocytopenia may also occur, and may result in petechiae or bleeding. Recurrent respiratory tract infections are occasionally serious .

Hematological malignancies are common.

Treatment

Pancreatic extracts are effective.

Treatment of skin and systemic infections .

  1. Neutrophil specific granule deficiency

    Neutrophils contain several types of granules. Azurophil granules contain myeloperoxidase, a wide variety of degradative enzymes and cationic proteins which have potent antibacterial and antifungal properties. Neutrophil specific granules are more numerous than azurophil granules. Lysozymes are also present in azurophil granules, lactoferrin and vitamin B-binding proteins.

    Affected individuals have increased susceptibility to infections, particularly cutaneous abscesses and recurrent pneumonia, leading to progressive lung damage.

  1. Myeloperoxidase deficiency

    Myeloperoxidase deficiency is relatively common, and is inherited as an autosomal recessive trait.

    Myeloperoxidase is a component of neutrophil azurophil granules. The generation of oxyhalide radicals and other toxic intermediaries are important to the cell‘s microbicidal activity. The myeloperoxidase gene has been localized to chromosome 17 .

Clinical Features

Defective neutrophil bacterial and fungal killing in vitro.

Incidence of bacterial infections is not increased.

Deep candida infections .

Complement deficiencies

Deficiency of C2 is the most frequent.

These are generally transmitted by autosomal recessive genes with the exception of C1 esterase inhibitor deficiency.

Clinical Manifestations

  • Bacterial infections:

  • Increased susceptibility to infection, most characteristically with Gram-negative diplococci such as Neisseria species.

  • Autoimmune diseases.

Deficiency of the early components of the classical complement activation pathway leads to different clinical manifestations depending on the type of deficient complement.

Manifestations of deficiency of different complements:

  1. C1, 4 and 2 deficiency predisposes to systemic lupus erythematosus in childhood.
     

  2. C2 and C4, deficiency is associated with an increased risk for certain diseases, notably systemic lupus erythematosus, discoid lupus erythematosus, juvenile rheumatoid arthritis, membranous glomerulonephritis and angioedema.

  3. C1 esterase inhibitor deficiency: results in hereditary angioedema.

    Cutaneous manifestations of lupus erythematosus.

    Photosensitivity.

  4. C1q deficiency: this may lead to:

    Systemic lupus erythematosus.

    Membranous glomerulonephritis.

    Infections, particularly meningitis , septicemia, stomatitis, pyoderma. Persistent candidiasis of mouth and nails.

  5. C1r and C1s deficiencies: The manifestations are:

    Systemic lupus erythematosus like manifestations.

    Membranous glomerulonephritis.

    Lung infections and hepatic abscesses.

  6. C4 deficiency

    Clinical manifestations are.

    Systemic lupus erythematosus or a SLE-like syndrome.

    Manifestations as Henoch-Schonlein purpura or Sjogren‘s syndrome.

    Infections.

  7. C2 deficiency

    This appears to be the most common complement deficiency. It has now been shown to be associated with a variety of diseases but deficient individuals are often entirely healthy.

Clinical Manifestations

The manifestations may simulate different diseases such as:

Collagen diseases as systemic lupus erythematosus, discoid lupus erythematosus, membranous glomerulonephritis, rheumatoid arthritis and dermatomyositis.

Henoch-Schonlein purpura.

Crohn‘s disease.

Idiopathic thrombocytopenic purpura.

Bacterial infections may also occur, particularly pneumococcal, Haemophilus influenza and Meningococcal infections.

  1. C3 deficiency

    Infections are the main hazard of C3 deficiency. Meningococcal meningitis and pneumococcal pneumonia are the major problems.

    Clinical Picture

    Similar to that of hypogammaglobulinaemia.

    Transient maculopapular rashes have been reported to occur in association with infections.

    Other manifestations such as systemic lupus erythematosus and membranous glomerulonephritis.

  1. C5, C6, C7, C8 and C9 deficiency

    Clinical Manifestations

    Recurrent meningococcal meningitis.

    Disseminated gonococcal infections.

    Cutaneous infections and subcutaneous abscesses in few cases.

    Collagen diseases as systemic lupus erythematosus, discoid lupus erythematosus, Sjo“gren‘s syndrome, rheumatoid arthritis, sclerodactaly, Raynaud‘s phenomenon and ankylosing spondylitis.

  

REFERNCES

  1. Brestei EP, Klingberg WG, Veltri RW et al. Osteogenesis imperfecta tarda in a child with hyper-IgE syndrome. Am J Dis Child 1982; 136: 774-6.

  2. Gilson IH, Banett JH, Conant MA et al. Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1989; 20: 637-42.

  3. Gretzula J, Penneys NS. Complex viral and fungal skin lesions of patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1987; 16: 1151-4.

  4. Miller ME, Seals J, Kaye R et al. A familial, plasma-associated defect of phagocytosis. Lancet 1968; ii: 60-3.

  5. Paller AS. Disorders of the immune system. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. New York: Churchill-Livingstone, 1988: 129-30.

  6. Patrizi A, Masina M, Tassoni P et al. Erythroderma in infancy: a sign of immunodeficiency? J Am Acad Dermatol 1987; 17: 694-5.

  7. Hill HR, Ochs HD, Quie PG et al. Defect in neutrophil granulocyte chemotaxis in Job‘s syndrome of recurrent ‘cold‘ abscesses. Lancet 1974; ii: 617-19.

  8. Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrent infection (Job‘s) syndrome. Medicine 1983; 62: 195-208.

  9. Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrent infection (Job‘s) syndrome. Medicine 1983; 62: 195-208.

  10. Buckley RH, Sampson HA. The hyperimmunoglobulin E syndrome. In: Franklin ED, ed. Clinical Immunology Update. New York: Elsevier 1981: 147-67.

  11. Buckley RH, Becker WG. Abnormalities in the regulation of human IgE synthesis. Immunol Rev 1978; 41: 288-314.

  12. Mawhinney J, Killen M, Fleming WA et al. The hyperimmunoglobulinemia E syndrome: a neutrophil chemotactic defect reversible by histamine H2 receptor blockade. Clin Immunol Immunopathol 1980; 17: 483-91.

  13. Morgan G, Hendrickse W, Harvey BAM et al. Treatment of the hyper-IgE syndrome with cimetidine. In: Vossen J, Griscelli C, eds. Progress in Immunodeficiency Research and Therapy II. Amsterdam, Elsevier, 1986: 217-20.

  14. Zachary CB, Atherton DJ. Hyper-IgE syndrome. Clin Exp Dermatol 1986; 11: 403-8.

  15. Evans DIK, Holzel A, MacFarlane H. Yeast opsonization defect and immunoglobulin deficiency in severe infantile dermatitis (Leiner‘s disease). Arch Dis Child. 1977; 52: 691-5.

  16. Nyhan WL. Inborn errors of biotin metabolism. Arch Dermatol 1987; 123: 1696-8.

  17. Paller AS. Disorders of the immune system. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. New York: Churchill-Livingstone, 1988: 129-30.

  18. Svejcar J, Homolka J. Experimental experiences with biotin in babies. Ann Paediatr 1950; 174: 175-93.

  19. Nyhan WL. Inborn errors of biotin metabolism. Arch Dermatol 1987; 123: 1696-8.

  20. Paller AS. Disorders of the immune system. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. New York: Churchill-Livingstone, 1988: 129-30.

  21. Svejcar J, Homolka J. Experimental experiences with biotin in babies. Ann Paediatr 1950; 174: 175-93.

  22. Super M, Thiel S, Lu J et al. Association of low levels of mannanbinding protein with a common defect of opsonisation. Lancet 1989; ii: 1236-9.

  23. Miller ME, Nilsson UR. A familial deficiency of the phagocytosisenhancing activity of serum related to a dysfunction of the fifth component of complement (C5). New Engl J Med 1970; 282: 354-8.

  24. Vujasin J, Petrovic D. Biotin in some erythemato-squamous dermatoses of babies. Dermatologica 1952; 105: 180-3.

  25. Brestei EP, Klingberg WG, Veltri RW et al. Osteogenesis imperfecta tarda in a child with hyper-IgE syndrome. Am J Dis Child 1982; 136: 774-6.

  26. Hill HR, Ochs HD, Quie PG et al. Defect in neutrophil granulocyte chemotaxis in Job‘s syndrome of recurrent ‘cold‘ abscesses. Lancet 1974; ii: 617-19.

  27. Karol RA, Eng J, Cooper JB et al. Imbalances in subsets of T lymphocytes in an inbred pedigree with Omenn‘s syndrome. Clin Immunol Immunopath 1983; 27: 412-27.

  28. Dreskin SC, Goldsmith PK, Gallin JI. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection syndrome. J Clin Invest 1985; 75: 26-34.

  29. Blum R, Geller G, Fish LA. Recurrent severe staphylococcal infections, eczematoid rash, extreme elevations of IgE, eosinophilia and divergent chemotactic responses in two generations. J Pediatr 1977; 90: 607-9.

  30. Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrent infection (Job‘s) syndrome. Medicine 1983; 62: 195-208.

  31. Walsh GA, Richards KL, Douglas SD et al. Immunoglobulin E anti-Staphylococcus aureus antibodies in atopic patients. J Clin Microbiol 1981; 13: 1046-8.

  32. Buckley RH, In: Stiehm ER, ed. Immunologic Disorders in Infants and Children. Philadelphia: WB Saunders, 1989: 320-6.

  33. Kamei R, Honig PJ. Neonatal Job‘s syndrome featuring a vesicular eruption. Pediatr Dermatol 1988; 5: 75-82.

  34. Hill HR, Ochs HD, Quie PG et al. Defect in neutrophil granulocyte chemotaxis in Job‘s syndrome of recurrent ‘cold‘ abscesses. Lancet 1974; ii: 617-19.

  35. Morgan G, Hendrickse W, Harvey BAM et al. Treatment of the hyper-IgE syndrome with cimetidine. In: Vossen J, Griscelli C, eds. Progress in

  36. Immunodeficiency Research and Therapy II. Amsterdam, Elsevier, 1986: 217-20.

  37. Walsh GA, Richards KL, Douglas SD et al. Immunoglobulin E anti-Staphylococcus aureus antibodies in atopic patients. J Clin Microbiol 1981; 13: 1046-8.

  38. Miller ME, Seals J, Kaye R et al. A familial, plasma-associated defect of phagocytosis. Lancet 1968; ii: 60-3.

  39. Brestei EP, Klingberg WG, Veltri RW et al. Osteogenesis imperfecta tarda in a child with hyper-IgE syndrome. Am J Dis Child 1982; 136: 774-6.

  40. Zachary CB, Atherton DJ. Hyper-IgE syndrome. Clin Exp Dermatol 1986; 11: 403-8.

  41. Morgan G, Hendrickse W, Harvey BAM et al. Treatment of the hyper-IgE syndrome with cimetidine. In: Vossen J, Griscelli C, eds. Progress in

  42. Immunodeficiency Research and Therapy II. Amsterdam, Elsevier, 1986: 217-20.

  43. Glover MT, Atherton DJ, Levinsky RJ. Syndrome of erythroderma, failure to thrive and diarrhea in infancy: a manifestation of immunodeficiency. Pediatrics 1988; 81: 66-72.

  44. Archer E, Chuang T-Y, Hong R. Severe eczema in a patient with DiGeorge‘s syndrome. Cutis 1990; 45: 455-9.

  45. DiGeorge AM. Congenital absence of the thymus and its immunologic consequences: occurrence with congenital hypoparathyroidism. Birth Defects 1968; 4: 116-23.

  46. Bastian JF, Williams RA, Ornelas W et al. Maternal isoimmunisation resulting in combined immunodeficiency and fatal graft-versus-host disease in an infant. Lancet 1984; 1: 1435-7.

  47. Weinberg K, Parkman R. Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. New Engl J Med 1990; 322: 1718-23.

  48. Gelfand EW, Dorsch HM. Diagnosis and classification of severe combined immunodeficiency disease. Birth Defects 1983; 19: 65-72.

  49. Schuurman HJ, Huber J, Zegers BJM et al. Placental diagnosis of the bare lymphocyte syndrome. New Engl J Med 1985; 313: 757-8.

  50. Paller AS. Disorders of the immune system. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. New York: Churchill-Livingstone, 1988: 129-30.

  51. Soothill JF, Harvey BAM. Defective opsonization: a common immunity deficiency. Arch Dis Child 1976; 51: 91-9.

  52. De Grouchy J, Turleau C. Clinical Atlas of Human Chromosomes. New York: John Wiley, 1984.

  53. Buckley RH, Sampson HA. The hyperimmunoglobulin E syndrome. In: Franklin ED, ed. Clinical Immunology Update. New York: Elsevier 1981: 147-67.

  54. Dreskin SC, Goldsmith PK, Gallin JI. Immunoglobulins in the hyperimmunoglobulin E and recurrent infection syndrome. J Clin Invest 1985; 75: 26-34.

  55. Buckley RH, In: Stiehm ER, ed. Immunologic Disorders in Infants and Children. Philadelphia: WB Saunders, 1989: 320-6.

  56. Mawhinney J, Killen M, Fleming WA et al. The hyperimmunoglobulinemia E syndrome: a neutrophil chemotactic defect reversible by histamine H2 receptor blockade. Clin Immunol Immunopathol 1980; 17: 483-91.

  57. Miller ME, Koblenzer PJ. Leiner‘s disease and deficiency of C5. J Pediatr 1972; 80: 879-80.

  58. Ochs HD, Davis SD, Mickelson E et al. Combined immunodeficiency and reticuloendotheliosis with eosinophilia. J Pediatr 1974; 85: 463-5.

  59. Auerbach AD, Min Z, Ghosh R et al. Clastogen-induced chromosomal breakage as a marker for first trimester prenatal diagnosis of Fanconi anemia. Hum Genet 1986; 73: 86-8.

  60. Gluckman E, Berger R, Dutreix J. Bone marrow transplantation for Fanconi anemia. Semin Hematol 1984; 21: 20-6.

  61. Jouan H, Le Diest F, Nezelof C. Omenn‘s syndrome: pathologic arguments in favor of a graft-versus-host pathogenesis. Hum Pathol 1987; 18: 1101-8.

  62. Baldini MG. Nature of the platelet defect in the Wiskott-Aldrich syndrome. Ann New York Acad Sci 1972; 201: 437-44.

  63. Blaese RM, Strober W, Waldmann TA. Immunodeficiency in the Wiskott-Aldrich syndrome. Birth Defects: Original Article Series 1975; XI(I): 250-4.

  64. Kwan S-P, Kandkuyl LA, Blaese M et al. Genetic mapping of the Wiskott-Aldrich syndrome with two highly linked polymorphic DNA markers. Genomics 1988; 3: 39-43.

  65. Mauer AM. X-linked recessive disorders: chronic granulomatous disease and Wiskott-Aldrich syndrome. J Invest Dermatol 1973; 60: 522-8.

  66. Peacocke M, Siminovitch KA. Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X-chromosome. Proc Natl Acad Sci USA 1987; 84: 3430-3.

  67. Rosen FS. T cell: B cell collaboration - the response to polysaccharide antigens. Semin Immunol 1989; 1: 87-91.

  68. Standen GR, Lillicrap DP, Matthews N et al. Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Quart J Med 1986; 59: 401-8.

  69. Ammann AJ, Hong R. Disorders of the T-cell system. In: Stiehm ER, ed. Immunological Disorders in Infants and Children. Philadelphia: WB Saunders, 1989: 280-5.

  70. Epstein WL, Reed W, Boder E et al. Dermatologic aspects of ataxia telangiectasia. Cutis 1968; 4: 1324-32.

  71. Peterson RDA, Funkhouser JD. Ataxia telangiectasia: an important clue. New Engl J Med 1990; 322: 124-5.

  72. Nyhan WL. Inborn errors of biotin metabolism. Arch Dermatol 1987; 123: 1696-8.

  73. Thoene J, Baker H, Yoshino M et al. Biotin-responsive carboxylase deficiency associated with subnormal plasma and urinary biotin. New Engl J Med 1981; 304: 817-23.

  74. Bonilla MA, Gillio AP, Ruggeiro M et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. New Engl J Med 1989; 320: 1574-80.

  75. Kostmann R. Infantile genetic agranulocytosis; a review with presentation of ten new cases. Acta Paediatr Scand 1975; 64: 362-8.

  76. Evans DIK, Holzel A, MacFarlane H. Yeast opsonization defect and immunoglobulin deficiency in severe infantile dermatitis (Leiner‘s disease). Arch Dis Child 1977; 52: 691-5.

  77. Nyhan WL. Inborn errors of biotin metabolism. Arch Dermatol 1987; 123: 1696-8.

Top

Contents << Previous Chapter Next Chapter >> Search